… The importance of NLRP3 inflammasome in immunity and human diseases has been well …
of NLRP3 inflammasome complex and of its activation was thought to be therapeutic strategy …

… Current therapeutic strategies targeting the NLRP3 axis consist of biologicals such as
anakinra, an IL-1β antagonist, and canakinumab, a neutralizing monoclonal antibody [76]. …

… Activation of the NLRP3 inflammasome results in IL-1β … the NLRP3 inflammasome as a
therapeutic strategy. A hypothetical mechanism for the action of the NLRP3 inflammasome in …

… basic mechanisms of inflammasome activation and their … NLRP3 inflammasome activation,
and discuss the current findings and therapeutic strategies that target NLRP3 inflammasome …

… of NLRP3 inflammasome inhibitors and their therapeutic … The development of a full range
of NLRP3 inflammasome … most potent therapeutic strategies and efficiently treat NLRP3 …

… The NLRP3 belongs to the subfamily of NLRP which activates … This inflammasome is
involved in multiple … Therefore, therapeutic targeting to the NLRP3 inflammasome complex is a …

… NLRP3 inflammasome in the pathophysiology of TBI, and current advances and challenges
in potential NLRP3-targeted therapies… effort to elucidate therapeutic strategies for attenuating …

… review also summarized the successful therapeutic approaches that target against NLRP3
… the successful therapeutic approaches that target against NLRP3 inflammasome for chronic …

… NLRP3 inflammasome activity in acute and chronic inflammatory diseases. By modulating
the conformation of the NLRP3 inflammasome, selective therapeutics … therapeutic strategies …

… and downstream signaling pathways of the NLRP3 inflammasome, as well as the latest
developments regarding its potential targets and therapeutic strategies for AD treatment. …